Compounded semaglutide uses the same active ingredient as Ozempic and Wegovy: semaglutide
To move Epitalon from experimental to evidence-based, several developments are essential: Randomized, double-blind, placebo-controlled clinical trials, ideally targeting specific endpoints (sleep, immune aging, telomere attrition) Toxicology and long-term safety studies, including exploration of stereoisomer effects and off-target consequences Validated delivery systems (e.g., dendrimer-conjugates, transdermal patches) that make real-world use feasible Pharmacodynamic biomarkers, to identify responders and track efficacy objectively over time Epitalon is not snake oil, but its also not a magic bullet
Clinical Status Human RCT | Observational | Animal | In vitro Primarily studied in preclinical and regional aging research contexts, with limited exploratory human data
| 2024 Edition Researchers interested in studying the potential benefits of BPC-157 will want to ensure that they source their reference materials from a legitimate vendor
This work and medical writing assistance for the preparation of this article was funded by Sandoz
GHK-Cu degrades rapidly below pH 5.0 or above pH 8.0